Fingerprint
Dive into the research topics of 'Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically